Experian Top FTSE 100 Index Fallers on Slowing Organic Revenue Growth
By Ian Walker
Experian shares were trading lower and leading the FTSE 100 index losers after the credit-reporting agency posted a slowing down of organic revenue growth.
Shares were down 79 pence, or 2.9%, at 26.30 pounds in early afternoon European trading. They are currently down 22% over the year to date.
The Dublin, Ireland-headquartered company said Thursday that organic revenue grew 7% in the first quarter compared with 9% in the fourth quarter of fiscal 2026.
In North America--the company's biggest region generating about 67% of group revenue--organic growth was 7%, compared with 9% in the second half of its last fiscal year.
Latin America--which generates 15% of group revenue--grew revenue 12% organically in line with the second half of fiscal 2026.
U.K. and Ireland organic revenue grew 5% in the first quarter, while EMEA and Asia Pacific grew 1% compared with 3% for both regions in the second half of fiscal 2026.
The company said its full-year expectations were unchanged. It previously forecast fiscal 2027 group organic revenue growth of 6% to 8% and double-digit benchmark earnings per share growth.
Revenue for the year ended March 31 was $8.445 billion, while benchmark EPS was 179.8 cents.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
July 16, 2026 07:41 ET (11:41 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States